We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

European Multicenter Study Radiofrequency (RF) Versus Cryo in Atrioventricular Nodal Reentry Tachycardia (AVNRT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00196222
Recruitment Status : Completed
First Posted : September 20, 2005
Last Update Posted : July 4, 2013
Sponsor:
Collaborator:
CryoCath Technologies Inc.
Information provided by (Responsible Party):
Deutsches Herzzentrum Muenchen

Brief Summary:
In this randomized study, two energy sources for the ablation of AV nodal reentry tachycardia are compared: The standard technique of radiofrequency energy delivery is compared with the new approach of cryo-energy application.

Condition or disease Intervention/treatment Phase
Atrioventricular Nodal Reentry Tachycardia Procedure: RF-ablation Procedure: cryo ablation Phase 4

Detailed Description:

The ablation of AV nodal reentry tachycardia with radiofrequency (RF) energy delivering catheters is a standard procedure and in experienced EP laboratories, the safety and efficacy of this approach is very high.

However, the potential complication of higher degree AV conduction block, requiring in some instances implantation of a pacemaker, is a major drawback of this approach.

We want to compare in this randomized study the safety and efficacy of standard RF ablation with the cryo-ablation technique. This relatively new technique is thought to offer more safety concerning higher degree AV conduction block.


Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 509 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: European Multicenter Study RF Versus Cryo in AVNRT: A Randomized Study Comparing Cryo-Energy vs. Radiofrequency-Energy Ablation Technique for AV Nodal Reentry Tachycardia (AVNRT)
Study Start Date : March 2003
Primary Completion Date : November 2008
Study Completion Date : May 2009

Arm Intervention/treatment
Experimental: 1
RF ablation/modulation of the slow pathway in AV nodal reentrant tachycardia
Procedure: RF-ablation
RF ablation/modulation of the slow pathway in AV nodal reentrant tachycardia
Experimental: 2
cryo energy ablation/modulation of the slow pathway in AV nodal reentrant tachycardia
Procedure: cryo ablation
Cryo ablation/modulation of the slow pathway in AV nodal reentrant tachycardia



Primary Outcome Measures :
  1. Combined endpoint of safety and efficacy of cryo ablation compared with RF ablation for procedure and 6 months follow-up data. [ Time Frame: 6 months ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 80 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Age between 18 and 80 years old
  • Clinical diagnosis of AVNRT (ECG/patients history)
  • Electrophysiologically confirmed (invasively assessed) diagnosis of AVNRT
  • Written informed consent

Exclusion Criteria:

  • Prior ablation for AVNRT
  • Congenital heart disease interfering with the ablation method
  • Prior cardiac surgery
  • Medical or psychiatric disorder interfering with study protocol or data acquisition
  • Exclusion of the patient by the study investigator

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00196222


Locations
Germany
Kerckhoffklinik GmbH EPU
Bad Nauheim, Germany, 61231
Charite Berlin Virchow - Klinikum Med. Klinik
Berlin, Germany, 13353
Universitaetsklinikum Bonn Med. Klinik II
Bonn, Germany, 53105
Evangelisches Krankenhaus Duesseldorf Kardiologie
Duesseldorf, Germany, 40217
Universitaetsklinikum Giessen EPU
Giessen, Germany, 35392
Klinikum Luedenscheid Kardiologie
Luedenscheid, Germany, 58515
Klinikum der Stadt Mannheim Med. Klinik I
Mannheim, Germany, 68167
Deutsches Herzzentrum Muenchen
Munich, Germany, 80636
Universitaetsklinikum Tuebingen Med. Klinik/Abt.III
Tuebingen, Germany, 72076
Universitaetsklinikum Ulm Innere Med. II
Ulm, Germany, 89075
Sponsors and Collaborators
Deutsches Herzzentrum Muenchen
CryoCath Technologies Inc.
Investigators
Study Chair: Claus Schmitt, MD Deutsches Herzzentrum Muenchen
Principal Investigator: Bernhard Zrenner, MD Deutsches Herzzentrum Muenchen